SEC Form 15-12G filed by Gracell Biotechnologies Inc.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER
SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION
OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 001-39838
GRACELL BIOTECHNOLOGIES INC.
(Exact name of registrant as specified in its charter)
Building 12, Block B, Phase II
Biobay Industrial Park
218 Sangtian St.
Suzhou Industrial Park, 215123
People’s Republic of China
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
American depositary shares (one American depositary share representing five ordinary shares, par value
US$0.0001 per share)
Ordinary shares, par value US$0.0001 per share
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
| Rule 12g-4(a)(1) | x | |
| Rule 12g-4(a)(2) | ¨ | |
| Rule 12h-3(b)(1)(i) | x | |
| Rule 12h-3(b)(1)(ii) | ¨ | |
| Rule 15d-6 | ¨ | |
| Rule 15d-22(b) | ¨ |
Approximate number of holders of record as of the certification or notice date: One.
Pursuant to the requirements of the Securities Exchange Act of 1934, Gracell Biotechnologies Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
| ||
| Date: March 4, 2024 | By: | /s/ David E. White |
| Name: | David E. White | |
| Title: | Director | |